Precision Therapy for Recurring Lung Cancer Patients

News   Mar 21, 2017 | Original story from University of Texas M. D. Anderson Cancer Center.

 
Precision Therapy for Recurring Lung Cancer Patients

Credit: University of Texas M. D. Anderson Cancer Center.

 
 
 
 

RELATED ARTICLES

FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies

News

Oncomine Dx Target Test returns results in days, helping physicians rapidly develop treatment plans for the most common form of lung cancer.

READ MORE

HIV Envelope Trimer Immunization Approach Optimized

News

Optimized immunizations reliably elicit protective antibodies in preclinical study, marking an important milestone on the way to an effective HIV vaccine.

READ MORE

BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-Oncology

News

QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE